What to do about Meth Labs?
November 10th, 2009 | No Comments | Source: Wall Street JournalA recent spike in illegal methamphetamine use and an associated proliferation of meth labs has prompted lawmakers to consider implementing a home-grown version of an Oregon law requiring that people who wish to purchase certain cold remedies must have a doctor’s prescription.
Meth labs use pseudoephedrine—an ingredient in many cold elixirs—to make the highly addictive stimulant.
Federal laws enacted 4 years ago limit the amount of pseudoephedrine-containing compounds that a person can purchase per month and per store visit. They also require pharmacies to track and report such purchases and to keep the drugs behind counters or in locked cabinets.
These laws cut meth utilization for 2 years, but meth producers have learned to circumvent them by deploying groups of people to purchase their limit and pooling the stash. And the number of meth labs nationwide has jumped from 3,000 in 2007 to 3,600 in 2008, authorities claim.
The same year that the Federal law went into effect, Oregon passed one of its own requiring a doctor’s prescription for drugs containing pseudoephedrine. Since then, meth-related arrests have dropped 43% and meth labs have nearly vanished in the state.
Those results prompted two cities in Missouri, Washington and Union, to pass ordinances modeled after Oregon’s law.
“To me, [what Oregon did] is the answer,” Richard Stratman, Washington’s mayor told the Wall Street Journal. “If you can tie up the pseudoephedrine and make it difficult to obtain, you can get the job maybe not completely done, but you can put a pretty good dent in those labs.”
More recently, lawmakers in Missouri and California introduced similar legislation and nationally, Oregon Senator Ron Wyden is planning to do the same later this year.
Companies that produce the cold remedies aren’t too keen on the proposals. The laws would “put a great burden not only on consumers but on the health-care system as well,” said Andrew Fish, who is the general counsel for a trade group representing the drug makers.




They found that federally-insured patients enrolled in such a program would cost over $1,000 per person per year, and that even after 25 years, only ¾ of those costs would be returned via reduced spending on dialysis, amputations and coronary heart disease.
At the top of the list are treatment strategies for common conditions like obesity and back pain and the prevention of falls in hospitalized patients. The list also includes mechanisms by which medical research findings are disseminated to the bedside and to the public.
With surely not a whit of political intent, the former Secretary told the
In sworn testimony yesterday before the Senate Budget Committee, Congress’ chief budget analyst lambasted the health reform proposals drafted by congressional Democrats in both chambers for
And today’s release by House Democrats of a
The deal reached between the American Hospital Association, the Federation of American Hospitals and the Catholic Health Association and both White House officials and Senate Finance Committee leaders follows a similar deal in which Big Pharma coughed up $80 billion toward the same end.
Last week, his argument got support from a report by the Council of Economic Advisors, which claimed that cutting annual growth in health-care spending from 6% to 4.5% could create 500,000 jobs per year and increase annual family income by $2,600 over the next decade.
Big Insurance, destined in this match to play Smokin’ Joe to the Big O’s Ali, released a wild haymaker of its own 2 hours before the Big O even showed up.
“If private insurers say that the marketplace provides the best quality health care, if they tell us that they’re offering a good deal, then why is it that the government — which they say can’t run anything — suddenly is going to drive them out of business?” Obama asked.
The draft also includes scaled-back coverage provisions that limit costs associated with the overhaul.
Take the time for example, when he lambasted HillaryCare’s proposals for employer mandates and regional insurance cooperatives. They “smack of excess government and the smell of socialism,” he said back then.
“That’s a pretty good record of bipartisanship,” Grassley told the Post.
Democratic senators Max Baucus of Montana, who chairs the Finance Committee, and Tom Harkin of Iowa, are behind the scheme.
The idea apparently won general acceptance during last week’s Senate Finance Committee meeting, and House Democratic opposition has begun to melt as well.
Massachusetts’ Edward Kennedy favors a Medicare-like government-sponsored plan that would compete with Big Insurance.
Meanwhile, New York Senator Charles Schumer has floated yet another proposal, in which the public plan would have to comply with the same rules and standards that apply to Big Insurance, including a requirement that it sustain itself with premiums rather than a money-tree over at Treasury.
Just 3 days after the Big O appeared to make serious hay out of last Monday’s announcement that key health care stakeholders were steppin’ up to
To make matters worse, Nancy-Ann DeParle, the director of the White House Office of Health Reform, then pulled a John Kerry by saying “the president misspoke,” and then saying “I don’t think the president misspoke. His remarks correctly and accurately described the industry’s commitment.”
Today it’s back to a thicket of problems that lie between us and reformland.




